Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 

Newsletter October 2009

Gene Therapy Net Banner
News: AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy. Orphan Drug Designation for Duchenne muscular dystrophy (DMD) entitles AMT to ten year market exclusivity in Europe following marketing approval for AMT-080 if this product candidate is the first new drug with a major medical benefit receiving marketing approval for the European Union. The designation also provides for special benefits, including research support, eligibility for protocol assistance and possible exemptions or reductions in certain regulatory fees during development or at the time of application for marketing approval.
Read more...
News: Scientists Use Gene Therapy To Cure Colorblind Monkeys
Scientists say they have used gene therapy to enable colorblind monkeys to see red and green, possibly opening the door to curing colorblindness in people. Jay Neitz of the University of Washington in Seattle and his colleagues injected gene-carrying viruses into the retinas of two male squirrel monkeys, which are naturally colorblind. The gene carried instructions for the production of a protein known as opsin, which makes pigments that are sensitive to the colors red and green. About five weeks after the treatment, the monkeys -- named Dalton and Sam -- began to develop the ability to see those colors, according to the results of detailed testing reported this week in the journal Nature.
Read more...
Conferences
- 2 -4 November 2009, Viral Vectors and Vaccines 16th International Meeting: For Pandemic Viruses, Cancer Vaccines, and Gene Therapy, New Orleans, LO
- 18 - 20 November 2009, 8th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, CA
- 18 - 21 November 2009, In Vivo Barriers to Gene Delivery, Cold Spring Harbor, NY
- 21 - 25 November 2009, European Society of Gene and Cell Therapy (ESGCT) 17th Annual Congress, Hannover, Germany
- 25 - 27 January 2010, Phacilitate Cell & Gene Therapy Forum 2010, Washington DC, MD
- 2 - 4 March 2010, DNA Vaccines 2010, New Orleans, LA
- 11 - 12 March 2010, Dutch Society of Gene Therapy (NVGT) Spring Meeting, The Netherlands
- 19 - 21 March 2010, British Society of Gene Therapy (BSGT) 7th Annual Conference, Royal Holloway University London, UK
- 19 – 23 May 2010, American Society of Gene and Cell Therapy (ASGCT) 13th Annual Meeting, Washington DC, MD
- 22 – 26 May 2010, International Society for Cellular Therapy (ISCT) 16th Annual Meeting, Philadelphia, PA
- 26 - 29 June 2010, 3nd International symposium on Cellular Delivery of Therapeutic Macromolecules, Cardiff, UK
- 1 - 3 July 2010, The 16th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tochigi-ken Sougou Bunka Center, Utsunomiya-city Tochigi, Japan
- 22 - 25 October 2010, European Society of Gene and Cell Therapy (ESGCT) 18th Annual Congress, Milan, Italy

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines, www.genetherapynet.com

Advertise on this site?